Concepedia

Perioperative change in CA125 is an independent prognostic factor for improved clinical outcome in advanced ovarian cancer

Maite Timmermans, Nienke Zwakman, Gabe S. Sonke, Koen Van de Vijver, M Jitze Duk, Maaike A. van der Aa, Roy F.P.M. Kruitwagen

European Journal of Obstetrics & Gynecology and Reproductive Biology · 2019 · 11 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Validation of a combined comorbidity index

Mary E. Charlson, Ted P. Szatrowski, Janey C. Peterson et al. · Journal of Clinical Epidemiology · 1994 · 6.6K citations

, , +12

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

Ignace Vergote, Claes G. Tropé, Frédéric Amant et al. · New England Journal of Medicine · 2010 · 2.5K citations · Full text

, , +17

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial

Sean Kehoe, Jane Hook, Matthew Nankivell et al. · The Lancet · 2015 · 1.4K citations

, , +14

Binding of Ovarian Cancer Antigen CA125/MUC16 to Mesothelin Mediates Cell Adhesion

Armin Rump, Yoshihiro Morikawa, Minoru Tanaka et al. · Journal of Biological Chemistry · 2004 · 586 citations · Full text

, , +15

TNM seventh edition: What's new, what's changed

Leslie H. Sobin, Carolyn C. Compton · Cancer · 2010 · 473 citations · Full text

, , +14